CAPITAL INTERNATIONAL LTD /CA/ - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL INTERNATIONAL LTD /CA/ ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2022$1,263,000
-23.3%
30,511
+10.6%
0.09%
-29.0%
Q2 2022$1,646,000
-22.1%
27,592
-5.2%
0.12%
+3.3%
Q1 2022$2,114,000
-62.6%
29,112
-56.7%
0.12%
-58.2%
Q4 2021$5,652,000
-3.9%
67,212
+3.0%
0.29%
-10.3%
Q3 2021$5,883,000
-6.6%
65,234
-1.3%
0.32%
-7.8%
Q2 2021$6,301,000
-16.7%
66,078
-0.5%
0.35%
-23.9%
Q1 2021$7,562,000
-31.5%
66,418
-16.7%
0.46%
-29.2%
Q4 2020$11,039,000
+70.6%
79,742
+1.3%
0.64%
+47.0%
Q3 2020$6,470,000
+36.0%
78,726
+29.4%
0.44%
-1.6%
Q2 2020$4,758,000
+76.1%
60,8260.0%0.44%
+46.9%
Q1 2020$2,702,000
+4.0%
60,8260.0%0.30%
+10.6%
Q4 2019$2,598,000
+41.5%
60,826
+41.7%
0.27%
-1.4%
Q3 2019$1,836,000
+38.3%
42,921
+105.2%
0.28%
-12.0%
Q2 2019$1,328,000
-1.4%
20,920
+7.7%
0.32%
-2.2%
Q1 2019$1,347,000
+86.6%
19,426
+17.0%
0.32%
+64.8%
Q4 2018$722,000
-43.0%
16,6000.0%0.20%
-50.4%
Q3 2018$1,267,000
-64.9%
16,600
-64.6%
0.40%
-37.4%
Q2 2018$3,610,000
+16.7%
46,957
-22.6%
0.63%
+13.9%
Q1 2018$3,093,000
+7.5%
60,657
-2.2%
0.55%
+1.5%
Q4 2017$2,878,000
-79.7%
62,034
-76.7%
0.55%
-41.7%
Q3 2017$14,194,000
-12.0%
266,500
+2.6%
0.94%
-12.3%
Q2 2017$16,130,000
+15.1%
259,700
+25.6%
1.07%
+17.1%
Q1 2017$14,011,000
+18.6%
206,718
+23.0%
0.91%
+10.4%
Q4 2016$11,813,000
+6.1%
168,018
+7.0%
0.83%
+5.1%
Q3 2016$11,138,000157,0000.79%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders